Department of Radiology
Found 5 results
Filters: Keyword is Cost-Benefit Analysis  [Clear All Filters]
2023
Subramanian K, Martinez J, Castellanos SHuicochea, Ivanidze J, Nagar H, Nicholson S, Youn T, Nauseef JT, Tagawa S, Osborne JR.  2023.  Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men.. Sci Rep. 13(1):8321.
Yun H, Kim J, Gandhe A, Nelson B, Hu JC, Gulani V, Margolis D, Schackman BR, Jalali A.  2023.  Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results.. JAMA Netw Open. 6(11):e2344856.
2011
Gomolin IH, Smith C, Jeitner TM.  2011.  Donepezil dosing strategies: pharmacokinetic considerations.. J Am Med Dir Assoc. 12(8):606-608.
2005
Larson SM, Nehmeh SA, Erdi YE, Humm JL.  2005.  PET/CT in non-small-cell lung cancer: value of respiratory-gated PET.. Chang Gung Med J. 28(5):306-14.
1997
George AE, de Leon MJ, Golomb J, Kluger A, Convit A.  1997.  Imaging the brain in dementia: expensive and futile? AJNR Am J Neuroradiol. 18(10):1847-50.